ArticleTranslational pediatrics2024

Blinatumomab improves outcomes for pediatric patients with low-risk B-cell acute lymphoblastic leukemia in first marrow relapse.

Lindsey Murphy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.